Evolus (EOLS) Stock Forecast, Price Target & Predictions
EOLS Stock Forecast
Evolus stock forecast is as follows: an average price target of $24.00 (represents a 84.05% upside from EOLS’s last price of $13.04) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.
EOLS Price Target
EOLS Analyst Ratings
Buy
Evolus Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Oct 03, 2024 | Douglas Tsao | H.C. Wainwright | $27.00 | $17.05 | 58.40% | 107.06% |
Sep 13, 2024 | Balaji Prasad | Barclays | $20.00 | $16.46 | 21.51% | 53.37% |
Sep 13, 2024 | Vamil Divan | Mizuho Securities | $25.00 | $16.46 | 51.88% | 91.72% |
Jan 29, 2024 | Balaji Prasad | Barclays | $16.00 | $13.47 | 18.78% | 22.70% |
10
Evolus Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 3 | 4 |
Avg Price Target | - | $24.00 | $22.00 |
Last Closing Price | $13.04 | $13.04 | $13.04 |
Upside/Downside | -100.00% | 84.05% | 68.71% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 03, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Sep 13, 2024 | Needham | Buy | Buy | Hold |
Sep 13, 2024 | Barclays | Overweight | Overweight | Hold |
Jan 29, 2024 | Barclays | - | Overweight | Upgrade |
Jan 17, 2024 | Needham | Buy | Buy | Hold |
Jan 17, 2024 | Cantor Fitzgerald | Buy | Buy | Hold |
Jun 24, 2022 | Needham | - | Buy | Initialise |
10
Evolus Financial Forecast
Evolus Revenue Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | $59.33M | $49.32M | $48.68M | $41.72M | $43.65M | $33.90M | $37.16M | $33.91M | $34.66M | $26.68M | $26.10M | $12.24M | $20.58M | $17.66M | $7.81M | $10.50M | $19.45M | $13.17M | $2.31M |
Avg Forecast | $105.81M | $84.43M | $81.95M | $75.38M | $76.96M | $63.17M | $64.93M | $57.27M | $60.19M | $44.35M | $49.30M | $40.57M | $43.89M | $36.00M | $36.60M | $29.83M | $34.76M | $25.41M | $24.67M | $11.11M | $21.20M | $11.51M | $1.93M | $15.24M | $18.02M | $3.97M | $341.17K |
High Forecast | $106.64M | $85.10M | $82.60M | $75.97M | $78.05M | $63.57M | $64.93M | $57.27M | $60.33M | $44.35M | $49.69M | $40.89M | $44.24M | $36.00M | $36.60M | $29.83M | $34.76M | $25.41M | $24.67M | $11.11M | $21.20M | $11.51M | $1.93M | $15.24M | $18.02M | $3.97M | $341.17K |
Low Forecast | $105.19M | $83.94M | $81.48M | $74.94M | $76.16M | $62.78M | $64.93M | $57.27M | $60.05M | $44.35M | $49.01M | $40.34M | $43.64M | $36.00M | $36.60M | $29.83M | $34.76M | $25.41M | $24.67M | $11.11M | $21.20M | $11.51M | $1.93M | $15.24M | $18.02M | $3.97M | $341.17K |
# Analysts | 1 | 1 | 1 | 1 | 4 | 2 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 |
Surprise % | - | - | - | - | - | - | - | - | 0.99% | 1.11% | 0.99% | 1.03% | 0.99% | 0.94% | 1.02% | 1.14% | 1.00% | 1.05% | 1.06% | 1.10% | 0.97% | 1.53% | 4.04% | 0.69% | 1.08% | 3.32% | 6.77% |
Forecast
Evolus EBITDA Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 4 | 2 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 |
EBITDA | - | - | - | - | - | - | - | - | $-25.21M | $-19.37M | $-20.05M | $-10.57M | $-9.45M | $-16.80M | $-18.52M | $-14.35M | $-2.49M | $-18.02M | $-13.38M | $9.24M | $-105.98M | $-6.82M | $-16.84M | $-15.10M | $-10.53M | $-23.30M | $-34.10M |
Avg Forecast | $-63.64M | $-50.78M | $-49.29M | $-45.34M | $-46.29M | $-38.00M | $-39.06M | $-22.98M | $-36.20M | $-26.67M | $-29.65M | $-20.89M | $-15.71M | $-23.01M | $-23.39M | $-18.99M | $-22.21M | $-16.24M | $-15.76M | $-7.10M | $-13.55M | $-7.36M | $-1.23M | $-11.01M | $-11.52M | $-2.54M | $-218.00K |
High Forecast | $-63.27M | $-50.49M | $-49.00M | $-45.07M | $-45.81M | $-37.76M | $-39.06M | $-18.39M | $-36.12M | $-26.67M | $-29.48M | $-16.71M | $-12.57M | $-23.01M | $-23.39M | $-15.19M | $-22.21M | $-16.24M | $-15.76M | $-7.10M | $-13.55M | $-7.36M | $-1.23M | $-8.81M | $-11.52M | $-2.54M | $-218.00K |
Low Forecast | $-64.14M | $-51.18M | $-49.68M | $-45.70M | $-46.94M | $-38.23M | $-39.06M | $-27.58M | $-36.29M | $-26.67M | $-29.89M | $-25.07M | $-18.85M | $-23.01M | $-23.39M | $-22.79M | $-22.21M | $-16.24M | $-15.76M | $-7.10M | $-13.55M | $-7.36M | $-1.23M | $-13.21M | $-11.52M | $-2.54M | $-218.00K |
Surprise % | - | - | - | - | - | - | - | - | 0.70% | 0.73% | 0.68% | 0.51% | 0.60% | 0.73% | 0.79% | 0.76% | 0.11% | 1.11% | 0.85% | -1.30% | 7.82% | 0.93% | 13.64% | 1.37% | 0.91% | 9.19% | 156.42% |
Forecast
Evolus Net Income Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 4 | 2 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 |
Net Income | - | - | - | - | - | - | - | - | $-11.83M | $-16.92M | $-18.14M | $-14.79M | $-13.16M | $-20.28M | $-23.47M | $-17.50M | $-18.18M | $-19.43M | $-15.60M | $6.40M | $-110.69M | $-11.46M | $-21.13M | $-19.73M | $-14.51M | $-26.98M | $-37.57M |
Avg Forecast | $1.58M | $-4.10M | $-1.26M | $1.58M | $1.52M | $-7.79M | $-3.32M | $-28.07M | $-7.81M | $-14.05M | $-15.97M | $-25.52M | $-21.64M | $-19.29M | $-16.41M | $-23.20M | $-14.07M | $-17.03M | $-16.31M | $8.84M | $-16.39M | $-25.01M | $-46.97M | $-14.38M | $-49.20M | $-72.68M | $-60.57M |
High Forecast | $1.59M | $-4.07M | $-1.25M | $1.59M | $30.31M | $-7.73M | $-3.29M | $-22.46M | $-5.58M | $-13.94M | $-15.85M | $-20.41M | $-17.31M | $-19.29M | $-16.41M | $-18.56M | $-14.07M | $-17.03M | $-16.31M | $10.61M | $-16.39M | $-25.01M | $-46.97M | $-11.51M | $-49.20M | $-72.68M | $-60.57M |
Low Forecast | $1.57M | $-4.15M | $-1.28M | $1.57M | $-25.76M | $-7.87M | $-3.35M | $-33.68M | $-10.05M | $-14.19M | $-16.13M | $-30.62M | $-25.97M | $-19.29M | $-16.41M | $-27.84M | $-14.07M | $-17.03M | $-16.31M | $7.07M | $-16.39M | $-25.01M | $-46.97M | $-17.26M | $-49.20M | $-72.68M | $-60.57M |
Surprise % | - | - | - | - | - | - | - | - | 1.51% | 1.20% | 1.14% | 0.58% | 0.61% | 1.05% | 1.43% | 0.75% | 1.29% | 1.14% | 0.96% | 0.72% | 6.76% | 0.46% | 0.45% | 1.37% | 0.29% | 0.37% | 0.62% |
Forecast
Evolus SG&A Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 4 | 2 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 |
SG&A | - | - | - | - | - | - | - | - | $43.06M | $43.33M | $41.17M | $37.38M | $36.73M | $34.79M | $36.88M | $33.44M | $33.28M | $31.68M | $26.47M | $20.68M | $27.39M | $21.94M | $17.55M | $33.05M | $31.75M | $32.10M | $35.87M |
Avg Forecast | $166.84M | $133.13M | $129.23M | $118.86M | $121.36M | $99.61M | $102.39M | $53.95M | $94.91M | $69.93M | $77.74M | $63.98M | $69.21M | $56.77M | $57.72M | $47.03M | $54.81M | $40.07M | $38.90M | $17.52M | $33.43M | $18.15M | $3.05M | $24.03M | $28.42M | $6.26M | $537.96K |
High Forecast | $168.16M | $134.18M | $130.24M | $119.80M | $123.07M | $100.23M | $102.39M | $64.74M | $95.13M | $69.93M | $78.35M | $64.48M | $69.76M | $56.77M | $57.72M | $47.03M | $54.81M | $40.07M | $38.90M | $17.52M | $33.43M | $18.15M | $3.05M | $24.03M | $28.42M | $6.26M | $537.96K |
Low Forecast | $165.87M | $132.35M | $128.47M | $118.17M | $120.10M | $99.00M | $102.39M | $43.16M | $94.70M | $69.93M | $77.28M | $63.60M | $68.81M | $56.77M | $57.72M | $47.03M | $54.81M | $40.07M | $38.90M | $17.52M | $33.43M | $18.15M | $3.05M | $24.03M | $28.42M | $6.26M | $537.96K |
Surprise % | - | - | - | - | - | - | - | - | 0.45% | 0.62% | 0.53% | 0.58% | 0.53% | 0.61% | 0.64% | 0.71% | 0.61% | 0.79% | 0.68% | 1.18% | 0.82% | 1.21% | 5.76% | 1.38% | 1.12% | 5.13% | 66.68% |
Forecast
Evolus EPS Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 4 | 2 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 |
EPS | - | - | - | - | - | - | - | - | $-0.00 | $-0.30 | $-0.00 | $-0.26 | $-0.23 | $-0.36 | $-0.42 | $-0.31 | $-0.33 | $-0.35 | $-0.31 | $0.17 | $-3.28 | $-0.34 | $-0.63 | $-0.59 | $-0.47 | $-0.98 | $-1.37 |
Avg Forecast | $0.03 | $-0.07 | $-0.02 | $0.03 | $0.02 | $-0.12 | $-0.05 | $-0.15 | $-0.12 | $-0.22 | $-0.25 | $-0.19 | $-0.17 | $-0.31 | $-0.26 | $-0.34 | $-0.22 | $-0.27 | $-0.26 | $-0.47 | $-0.26 | $-0.40 | $-0.75 | $-0.64 | $-0.78 | $-1.16 | $-0.97 |
High Forecast | $0.03 | $-0.06 | $-0.02 | $0.03 | $0.48 | $-0.12 | $-0.05 | $-0.15 | $-0.09 | $-0.22 | $-0.25 | $-0.18 | $-0.17 | $-0.31 | $-0.26 | $-0.34 | $-0.22 | $-0.27 | $-0.26 | $-0.47 | $-0.26 | $-0.40 | $-0.75 | $-0.64 | $-0.78 | $-1.16 | $-0.97 |
Low Forecast | $0.02 | $-0.07 | $-0.02 | $0.02 | $-0.41 | $-0.12 | $-0.05 | $-0.15 | $-0.16 | $-0.22 | $-0.26 | $-0.19 | $-0.17 | $-0.31 | $-0.26 | $-0.34 | $-0.22 | $-0.27 | $-0.26 | $-0.47 | $-0.26 | $-0.40 | $-0.75 | $-0.64 | $-0.78 | $-1.16 | $-0.97 |
Surprise % | - | - | - | - | - | - | - | - | 0.00% | 1.35% | 0.00% | 1.40% | 1.37% | 1.17% | 1.61% | 0.91% | 1.47% | 1.29% | 1.19% | -0.37% | 12.56% | 0.85% | 0.84% | 0.92% | 0.60% | 0.85% | 1.42% |
Forecast
Evolus Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
PROC | Procaps Group | $1.11 | $10.00 | 800.90% | - |
PCRX | Pacira BioSciences | $17.38 | $35.00 | 101.38% | Hold |
EOLS | Evolus | $13.04 | $24.00 | 84.05% | Buy |
AMPH | Amphastar Pharmaceuticals | $44.55 | $66.00 | 48.15% | Buy |
ANIP | ANI Pharmaceuticals | $55.86 | $79.00 | 41.42% | Buy |
COLL | Collegium Pharmaceutical | $30.41 | $40.50 | 33.18% | Buy |
ALKS | Alkermes | $27.70 | $36.38 | 31.34% | Hold |
ITCI | Intra-Cellular Therapies | $85.45 | $94.50 | 10.59% | Buy |
PBH | Prestige Consumer Healthcare | $84.14 | $89.50 | 6.37% | Buy |
SUPN | Supernus Pharmaceuticals | $35.82 | $38.00 | 6.09% | Buy |
DCPH | Deciphera Pharmaceuticals | $25.59 | $26.32 | 2.85% | Hold |
PAHC | Phibro Animal Health | $23.76 | $18.67 | -21.42% | Buy |